Anti-AIDS agents. 34. Synthesis and structure-activity relationships of betulin derivatives as anti-HIV agents

Journal of Medicinal Chemistry

Volumn 41, Issue 23, 1998, Pages 4648-4657

  Sun, I Chen ^a   Wang, Hui Kang ^a   Kashiwada, Yoshiki ^b   Shen, Jing Kang ^a   Cosentino, L Mark ^c   Chen, Chin Ho ^d   Yang, Li Ming ^e   Lee, Kuo Hsiung ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^c BBI Biotech Research Laboratories   (United States)

^d MEHARRY MEDICAL COLLEGE   (United States)

^e NATIONAL RESEARCH INSTITUTE OF CHINESE MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3,28 DI O (3',3' DIMETHYLGLUTARYL)BETULIN; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETULIC ACID; BETULIN DERIVATIVE; ENFUVIRTIDE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LEUKEMIA CELL; MOUSE; STRUCTURE ACTIVITY RELATION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0032487840     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm980391g     Document Type: Article

References (31)

1. Xie, L.; Takeuchi, Y.; Cosentino, L. M.; Lee, K, H. Anti-AIDS Agents. 33. Synthesis and Anti-HIV Activity of Monomethyl Substituted 3′,4′-Di-O-(-)-Camphanoyl-(+)-cis-Khellactone (DCK) Analogues. Bioorg. Med. Chem. Lett. 1998, 8, 2151-2156.
2. Coffin, J. M. HIV Population Dynamics in vivo: Implications for Genetic Variation, Pathogenesis, and Therapy. Science 1995, 267, 483-489.
3. Gulick, R. M.; Mellors, J. W.; Havlir, D.; Eron, J. J.; Gonzalez, C.; McMahon, D.; Richmann, D. D.; Valentine, F. T.; Jonas, L.; Meibohm, A.; Emini, E. A.; Chodakewitz, J. A. Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy. N. Eng. J. Med. 1997, 337, 734-739.
4. Chun, T. W.; Carruth, L.; Finzi, D.; Shen, X.; DiGiuseppe, J. A.; Taylor, H.; Hermankova, M.; Chadwick, K.; Margolick, J.; Quinn, T. C.; Kuo, Y. H.; Brookmeyer, R.; Zeiger, M. A.; Barditch-Crovo, P.; Siliciano, R. F. Quantification of Latent Tissue Reservoirs and Total Body Viral Load in HIV-1 Infection. Nature 1997, 387, 183-188.
5. Wong, J. K.; Hezareh, M.; Gunthard, H. F.; Havlir, D. V.; Ignacio, C. C.; Spina, C. A.; Richman, D. D. Recovery of Replication Competent HIV Despite Prolonged Suppression of Plasma Viremia. Science 1997, 278, 1291-1295.
6. Finzi, D.; Hermankova, M.; Pierson, T.; Carruth, L. M.; Buck, C.; Chaisson, R. E.; Wuinn, T. C.; Chardwick, K.; Margolick, J.; Brookmeyer, R.; Gallant, J.; Markowitz, M.; Ho, D. D.; Richman, D. D.; Siliciano, R. F. Identification of a Reservoir of HIV-1 in Patients on Highly Active Antiretroviral Therapy. Science 1997, 278, 1295-1300.
7. Pengsuparp, T.; Cai, L.; Fong, H. H. S.; Kinghorn, A. D.; Pezzuto, J. M.; Wani, M.; Wall, M. E. Pentacyclic Triterpenes Derived from Maprounea africana are Potent Inhibitors of HIV-1 Reverse Transcriptase. J. Nat. Prod. 1994, 57, 415-418.
8. Xu, H. X.; Zeng, F. Q.; Wan, M.; Sim, K. Y. Anti-HIV Triterpene Acids from Geum japonicum. J. Nat. Prod. 1996, 59, 643-645.
9. Ito, M.; Nakashima, H.; Baba, M.; Pauwels, R.; DeClercq, E.; Shigeta, A.; Yamamoto, N. Inhibitory Effect of Glycyrrhizin on the in vitro Infectivity and Cytopathic Activity of the Human Immunodeficiency Virus. Antiviral Res. 1987, 7, 127-137.
10. Nakashima, H.; Matsui, T.; Yoshida, O.; Isowa, Y.; Kido, Y.; Motoki, Y.; Ito, M.; Shigeta, S.; Mori, T.; Yamamoto, N. A New Anti-human Immunodeficiency Virus Substance, Glycyrrhizin Sulfate; Endowment of Glycyrrhizin with Reverse Transcriptase Inhibitory Activity by Chemical Modification. Jpn J. Cancer Res. 1987, 78, 767-771.
11. Chen, K.; Shi, Q.; Kashiwada, Y.; Zhang, D. C.; Hu, C. Q.; Jin, J. Q.; Nozaki, H.; Kilkuskie, R. E.; Tramontano, E.; Cheng, Y. C.; McPhail, D. R.; McPhail, A. T.; Lee, K. H. Anti-AIDS Agents, 6. Salaspermic Acid, an Anti-HIV Principle from Tripterygium wilfordii, and the Structure-activity Correlation with Its Related Compounds. J. Nat. Prod. 1992, 55, 340-346.
12. Abdallah, R. M.; Ghazy, N. M.; El-Sebakhy, N. A.; Pirillo, A.; Verotta, L. Astragalosides from Egyptian Astragalus spinosus Vahl. Pharmazie 1993, 48, 452-454.
13. 31 Lanostane-type Triterpene and Anti-HIV Principle from Polyalthia suberosa. J. Nat. Prod. 1993, 56, 1130-1133.
14. Fujioka, T.; Kashiwada, Y.; Kilkuskie, R. E.; Cosentino, L. M.; Ballas, L. M.; Jiang, J. B.; Janzen, W. P.; Chen, I. S.; Lee, K. H. Anti-AIDS Agents, 11. Betulinic Acid and Platanic Acid as Anti-HIV Principles from Syzygium claviflorum, and the Anti-HIV Activity of Structurally Related Triterpenoids. J. Nat. Prod. 1994, 57, 243-247.
15. Kashiwada, Y.; Hashimoto, F.; Cosentino, L. M.; Chen, C. H.; Garrett, P. E.; Lee, K. H. Betulinic Acid and Dihydrobetulinic Acid Derivatives as Potent Anti-HIV Agents. J. Med. Chem. 1996, 30, 1016-1017.
16. Hashimoto, F.; Kashiwada, Y.; Cosentino, L. M.; Chen, C. H.; Garrett, P. E.; Lee, K. H. Anti-AIDS Agents, 26. Synthesis and Anti-HIV Activity of Betulinic Acid and Dihydrobetulinic Acid Derivatives. Bioorg. Med. Chem. 1997, 5, 2133-2143.
17. Mayaux, J. F.; Bousseau, A.; Pauwels, R.; Huet, T.; Hénin, Y.; Dereu, N.; Evers, M.; Soler, F.; Poujade, C.; De Clercq, E.; Le Pecq, J.-B. Triterpene Derivatives That Block Entry of Human Immunodeficiency Virus Type 1 into Cells. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 3564-3568.
18. Soler, F.; Poujade, C.; Evers, M.; Carry, J. C.; Hénin, Y.; Bousseau, A.; Huet, T.; Pauwels, R.; De Clercq, E.; Mayaux, J. F.; Le Pecq, J. B.; Dereu, N. Betulinic Acid Derivatives: a New Class of Specific Inhibitors of Human Immunodeficiency Virus Type 1 Entry. J. Med. Chem. 1996, 39, 1069-1083.
19. According to the Aldrich catalog 1997-1998, 500 mg of betulin and betulinic acid costs $15.54 and $108.05 USD, respectively. Betulin is 7 times cheaper than that of betulinic acid.
20. Wang, B. H.; Polya, G. M. Selective Inhibition of Cyclic AMP-dependent Protein Kinase by Amphiphilic Triterpenoids and Related Compounds. Phytochemistry 1996, 41, 55-63.
21. Recio, M. C.; Giner, R. M.; Manez, S.; Gueho, J.; Julien, H. R.; Hostemann, K.; Rios, J. L. Investigations on the Steroidal Anti-inflammatory Activity of Triterpenoids from Diospyros leucomelas. Planta Med. 1995, 61, 9-12.
22. Sun, I. C.; Shen, J. K.; Wang, H. K.; Cosentino, L. M.; Lee, K. H. Anti-AIDS Agents. 32. Synthesis and Anti-HIV Activity of Betulin Derivatives. Bioorg. Med. Chem. Lett. 1998, 8, 1267-1272.
23. Evers, M.; Poujade, C.; Soler, F.; Ribeill, Y.; James, C.; Leliévre, Y.; Gueguen, J. C.; Reisdorf, D.; Morize, I.; Pauwels, R.; De Clercq, E.; Hénin, Y.; Bousseau, A.; Mayaux, J. F.; Le Pecq, J. B.; Dereu, N. Betulinic Acid Derivatives: a New Class of Human Immunodeficiency Virus Type 1 Specific Inhibitors with a New Mode of Action. J. Med. Chem. 1996, 39, 1056-1068.
24. Corey, E. J.; Suggs, J. W. Pyridinium chlorochrornate. An Efficient Reagent for Oxidation of Primary and Secondary Alcohols to Carbonyl Compounds. Tetra. Lett. 1975, 31, 2647-2650.
25. Negi, S.; Matsukura, M.; Mizuno, M.; Miyake, K.; Minami, N. Synthesis of (2R)-1-(4-Chloro-2-pyridyl)-2-(2-pyridyl)ethylamine : A Selective Oxime Reduction and Crystallization-induced Asymmetric Transformation. Synthesis 1996, 991-996.
26. Leeds, J. P.; Kirst, H. A. A Mild Single-step Reduction of Oximes to Amines. Synth. Commun. 1988, 18, 777-782.
27. Reeder, A. Y.; Joannou, G. E. 15β-Hydroxysteroids (part IV). Steroids of the Human Perinatal Period: the Synthesis of 3α, 15β, 17α-Trihydroxy-5α-pregnan-20-one and Its A/B-ring Conflgurational Isomers. Steroids 1995, 60, 796-801.
28. Bose, A. K.; Lal, B.; Huffman III, R. A.; Manhas, M. S. Steroids. IX. Facile Inversion of Unhindered Sterol Configuration. Tetrahedron Lett. 1973, 18, 1619-1622.
29. Wild, C. T.; Shugars, D. C.; Greenwell, T. K.; McDanal, C. B.; Matthews, T. J. Peptides Corresponding to a Predictive α-Helical Domain of Human Immunodeficiency Virus Type 1 gp41 Are Potent Inhibitors of Virus Infection. Proc. Natl. Acad. Sci. U.S.A. 1994, 91, 9770-9774.
30. Mathews, T. J.; Weinhold, K. J.; Lyerly, H. K.; Langlois, A. J.; Wigzell, H.; Bolognesi, D. P. Interaction Between the Human T-cell Lymphotropic Viurs Type III Envelope Glycoprotein gp120 and the Surface Antigen CD4: Role of Carbohydrate in Binding and Cell Fusion. Proc. Natl. Acad. Sci. U.S.A. 1987, 84, 5424-5428.
31. Kimpton, J.; Emerman, M. Detection of Replication Competent and Pseudotyped Human Immunodeficiency Virus with a Sensitive Cell Line on the Basis of Activation of an Integrated β-Galactosidase Gene. J. Viol. 1992, 66, 2232-2239.